3-(2-methylpyridin-4-yl)-N-((2,3,5-trichloropyridin-4-yl)methyl)-1H-indazole-5-carboxamide

ID: ALA3797917

Chembl Id: CHEMBL3797917

PubChem CID: 127045826

Max Phase: Preclinical

Molecular Formula: C20H14Cl3N5O

Molecular Weight: 446.73

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cc(-c2n[nH]c3ccc(C(=O)NCc4c(Cl)cnc(Cl)c4Cl)cc23)ccn1

Standard InChI:  InChI=1S/C20H14Cl3N5O/c1-10-6-11(4-5-24-10)18-13-7-12(2-3-16(13)27-28-18)20(29)26-8-14-15(21)9-25-19(23)17(14)22/h2-7,9H,8H2,1H3,(H,26,29)(H,27,28)

Standard InChI Key:  RPEZEVLVOQKGCV-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3797917

    ---

Associated Targets(Human)

MAPK3 Tchem MAP kinase ERK1 (4725 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK1 Tchem MAP kinase ERK2 (25055 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 446.73Molecular Weight (Monoisotopic): 445.0264AlogP: 5.22#Rotatable Bonds: 4
Polar Surface Area: 83.56Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.21CX Basic pKa: 4.37CX LogP: 3.86CX LogD: 3.86
Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.42Np Likeness Score: -1.40

References

1. Li L, Liu F, Jin N, Tang S, Chen Z, Yang X, Ding J, Geng M, Jiang L, Huang M, Cao J..  (2016)  Discovery and structure activity relationship study of novel indazole amide inhibitors for extracellular signal-regulated kinase1/2 (ERK1/2).,  26  (11): [PMID:27106711] [10.1016/j.bmcl.2016.04.029]

Source